tiprankstipranks
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market
DMAC
Diamedica Therapeutics
RESEARCH TOOLSreports
Want to see DMAC full AI Analyst Report?

Diamedica Therapeutics (DMAC) Income Statement

571 Followers

Diamedica Therapeutics Income Statement

Last quarter (Q4 2025), Diamedica Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Diamedica Therapeutics's net income was $-8.74M. See Diamedica Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 34.40M$ 26.68M$ 21.27M$ 14.00M$ 13.65M
Depreciation and Amortization
$ 43.00K$ 39.00K$ 30.00K$ 25.00K$ 24.00K
EBITDA
$ -34.35M$ -26.64M$ -21.24M$ -13.98M$ -13.62M
Operating Income
$ -34.40M$ -26.68M$ -21.27M$ -14.00M$ -13.65M
Other Income/Expenses
$ 1.66M$ 2.27M$ 1.93M$ 353.00K$ 82.00K
Pretax Income
$ -32.74M$ -24.41M$ -19.34M$ -13.65M$ -13.56M
Net Income
$ -32.77M$ -24.44M$ -19.38M$ -13.68M$ -13.59M
Per Share Metrics
Basic EPS
$ -0.70$ -0.60$ -0.60$ -0.52$ -0.65
Diluted EPS
$ -0.70$ -0.60$ -0.60$ -0.52$ -0.65
Weighted Average Shares Outstanding
 46.98M 40.40M 32.57M 26.44M 20.77M
Weighted Average Shares Outstanding (Diluted)
 46.98M 40.40M 32.57M 26.44M 20.77M
Currency in USD

Diamedica Therapeutics Earnings and Revenue History